Companies: 10,795·Total market cap: $144.5T
Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc.

HOWLNASDAQHealthcare● Active
$0.37
$-0.01(-1.86%)
Market Cap$18214081
P/E Ratio—
52W High$2.38
52W Low$0.37
Cash on HandFinancialsRevenue

Werewolf Therapeutics, Inc. (HOWL) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

HOWL · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$58.0M▼ -47.8% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$58.0M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-47.8%
vs prior fiscal year
Latest Quarter
$46.5M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$58.0MCash on Hand
Total Debt$9.4MTotal Debt
Net Cash / Net Debt+$48.5MNet Cash Position
Cash vs Debt Ratio
Cash 86%Debt 14%

Werewolf Therapeutics, Inc. has a net cash position of $48.5M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$58.0M − $9.4M = +$48.5M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
HOWL annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$58.0M-47.8%
Dec 31, 2024$111.0M-17.4%
Dec 31, 2023$134.3M+3.9%
Dec 31, 2022$129.3M-17.9%
Dec 31, 2021$157.5M+70.2%
HOWL cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc.YOU
HOWL
$58.0M312.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Werewolf Therapeutics, Inc. (HOWL) cash on hand as of December 31, 2025 is $58.0M, comprising $58.0M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Werewolf Therapeutics, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Werewolf Therapeutics, Inc. cash reserves or cash position.

Werewolf Therapeutics, Inc. annual cash on hand history shows decreased -47.8% in 2025: decreased -47.8% in 2025. Werewolf Therapeutics, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Werewolf Therapeutics, Inc. carries total debt of $9.4M against cash of $58.0M, resulting in a net cash position of +$48.5M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

HOWL cash on hand · 5 questions

As of December 31, 2025, Werewolf Therapeutics, Inc. (HOWL) has $57,951,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $57,951,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $46,450,000. Data sourced from the annual 10-K filing via FMP.

HOWL cash on handHOWL cash reservesHOWL cash 2025how much cash does HOWL have

▸ Source: FMP /balance-sheet-statement · US GAAP · Werewolf Therapeutics, Inc. · Werewolf Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025